Guided Therapeutics Revenue

In the year 2024, Guided Therapeutics had annual revenue of $7.00K, down -92.86%. Guided Therapeutics had revenue of $1,000.00 in the quarter ending December 31, 2024, a decrease of -96.88%.

Revenue

7.00K

Revenue Growth

-92.86%

P/S Ratio

1,211.28

Revenue / Employee

1.75K

Employees

Market Cap

8.48M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.00K	-91.00K	-92.86%
Dec 31, 2023	98.00K	85.00K	653.85%
Dec 31, 2022	13.00K	-68.00K	-83.95%
Dec 31, 2021	81.00K	-21.00K	-20.59%
Dec 31, 2020	102.00K	66.00K	183.33%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.76B
Veradigm	588.02M
Glass House Brands	200.90M
Northwest Biotherapeutics	1.38M
Elite Pharmaceuticals	70.00M
BioStem Technologies	301.83M
American Oncology Network	1.76B
Silence Therapeutics	43.26M

Revenue Rankings

Guided Therapeutics News

4 months ago - Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables - Business Wire
10 months ago - Guided Therapeutics' Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites With Better Than Expected Results - Business Wire
1 year ago - Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results - Business Wire
1 year ago - Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval - Business Wire

More News